Results 111 to 120 of about 416 (129)
Some of the next articles are maybe not open access.

Exploring the role of senescence inducers and senotherapeutics as targets for anticancer natural products

European Journal of Pharmacology, 2022
Abdullah Al Mamun   +2 more
exaly  

Senotherapeutic approach to age-related endocrine diseases

Senescent cells progressively accumulate in the endocrine glands and their target tissue during the biological aging process. Senescence leads to hormonal imbalances contributing to various age-related endocrine diseases (AREDs). Cellular senescence, characterized by irreversible cell-cycle arrest, becomes more prevalent in advanced age, and the ...
Turgut, Seydanur, Andican, Gülnur
openaire   +3 more sources

Cellular senescence and senotherapeutics in cardiovascular diseases

Cellular senescence (CS) is characterized by stable cell cycle arrest and is resistant to growth-promoting stimuli allied with aging. Cardiac senescent cells (SCs) are highly heterogeneous cells that can regulate the pathophysiology of cardiovascular diseases (CVDs).
openaire   +2 more sources

Senotherapeutic biorevitalization

Pharmateca
Kholupova L.S. Kholupova   +2 more
openaire   +1 more source

Senotherapeutics

Razia Khanam, Divya Vohora
openaire   +1 more source

Senotherapeutics in Cancer

Gurpreet Kaur   +5 more
openaire   +1 more source

SENOTHERAPEUTIC SUBSTANCE

2022
RUSSO VENERA   +4 more
openaire   +1 more source

Origin of Senotherapeutics

Vaishali Yadav   +3 more
openaire   +1 more source

Senotherapeutics and Diabetes

Aleeta Maria Jolly   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy